A cost-effectiveness comparison of olanzapine and risperidone in the treatment of schizophrenia in Italy

D Berardi; M Nardini; F Ramacciotti; L Giudi; M Lothgren; Stephen Beard

RTI uses cookies to offer you the best experience online. By and clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.

A cost-effectiveness comparison of olanzapine and risperidone in the treatment of schizophrenia in Italy

Beard, S., Lothgren, M., Giudi, L., Ramacciotti, F., Nardini, M., & Berardi, D. (2002). A cost-effectiveness comparison of olanzapine and risperidone in the treatment of schizophrenia in Italy. Value in Health, 5(6), 515-515.

Copy citation

Recent Publications

A cost-effectiveness comparison of olanzapine and risperidone in the treatment of schizophrenia in Italy

Publications Info

Recent Publications

Article

"Show Me the Energy Costs"

Article

Validation of a brief internalized sex-work stigma scale among female sex workers in Kenya

Article

Defining the social determinants of health for nursing action to achieve health equity

Article

Incorporating qualitative research methods into the monitoring and evaluation of neglected tropical disease programmes